Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C R George

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Lancet (London, England)|April 15, 1972
Cyclophosphamide and infertilityP H Feng, C R George, R A Evans, et al.
Kidney International|March 1, 1994
Effects of erythropoietin therapy on the lipid profile in end-stage renal failureC A Pollock, R Wyndham, P V Collett, et al.
The Quarterly Journal of Medicine|May 1, 1985
The pathogenesis of renal osteodystrophy: role of vitamin D, aluminium, parathyroid hormone, calcium and phosphorusC R Dunstan, E Hills, A W Norman, et al.
Mineral and Electrolyte Metabolism|January 1, 1985
Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combinationC R Dunstan, E Hills, A W Norman, et al.
The Medical Journal of Australia|December 4, 1989
Thin-membrane nephropathy--a common cause of glomerular haematuriaG J Perry, C R George, M J Field, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Lancet (London, England)|April 15, 1972
Cyclophosphamide and infertilityP H Feng, C R George, R A Evans, et al.
Kidney International|March 1, 1994
Effects of erythropoietin therapy on the lipid profile in end-stage renal failureC A Pollock, R Wyndham, P V Collett, et al.
The Quarterly Journal of Medicine|May 1, 1985
The pathogenesis of renal osteodystrophy: role of vitamin D, aluminium, parathyroid hormone, calcium and phosphorusC R Dunstan, E Hills, A W Norman, et al.
Mineral and Electrolyte Metabolism|January 1, 1985
Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combinationC R Dunstan, E Hills, A W Norman, et al.
The Medical Journal of Australia|December 4, 1989
Thin-membrane nephropathy--a common cause of glomerular haematuriaG J Perry, C R George, M J Field, et al.
Pageof 7